We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current COEP market cap is 27.14M. The company's latest EPS is USD -10.3442 and P/E is -1.16.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.81M | -3.63M | -2.92M | -2.83M | -2.14M |
| Net Income | -6.26M | -4.03M | -3M | -3.04M | -1.83M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2k | -68k | -681k | -34.2M | -21.49M |
| Net Income | -2k | -67k | 15.23M | -37.57M | -21.27M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.17M | 8.07M | 9.39M | 4.2M | 8.96M |
| Total Liabilities | 2.16M | 3.76M | 5.04M | 4.51M | 3.97M |
| Total Equity | 5.01M | 4.31M | 4.36M | -310k | 4.98M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 172k | 76.71M | 76.17M | 7.92M | 8.07M |
| Total Liabilities | 156k | 2.26M | 7.19M | 3.11M | 3.76M |
| Total Equity | 16k | 5M | -6.77M | 4.8M | 4.31M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.55M | -7.24M | -1.9M | -3.32M | -5.21M |
| Investing | N/A | N/A | -100k | -100k | -100k |
| Financing | 3.17M | 4.92M | 1.56M | 3.51M | 4.98M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2k | -116k | -503k | -3.88M | -7.24M |
| Investing | N/A | -75.75M | N/A | N/A | N/A |
| Financing | 2k | 76.77M | N/A | 5.49M | 4.92M |
| Market Cap | 27.14M |
| Price to Earnings Ratio | -1.16 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 16.72 |
| Price to Book Ratio | 5.7 |
| Dividend Yield | - |
| Shares Outstanding | 2.06M |
| Average Volume (1 week) | 120.41k |
| Average Volume (1 Month) | 218.26k |
| 52 Week Change | 13.79% |
| 52 Week High | 13.70 |
| 52 Week Low | 2.31 |
| Spread (Intraday) | 1.34 (9.93%) |
| Company Name | Coeptis Therapeutics Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.coeptistx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
